Posted On: 12/29/2013 9:11:27 PM
Post# of 131
SVFC. NEW YORK, NY--(Marketwired - Nov 12, 2013) - IntelliCell Biosciences, Inc. ( OTCQB : SVFC ), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it has supplied its cellular product, stromal vascular fraction cells ("SVFC"), to ReGen Medical PC for the successful treatment of a patient with Multiple Sclerosis.
It is important to note that by "successful," the company is declaring that these cells do not cure Multiple Sclerosis, but of the 19 patients with MS that ReGen Medical has treated using IntelliCell's technology, each have gained anywhere from good to significant quality of life improvements.
http://finance.yahoo.com/news/intellicell-bio...00562.html
http://www.intellicellbiosciences.com/intellicell-facts.html
(0)
(0)
